#United States #healthcare #Washington #investor conference #Vanda Pharmaceuticals

Vanda Pharmaceuticals Set to Engage at Major Investor Conferences

Vanda Pharmaceuticals Inc., listed on the Nasdaq with the ticker VNDA, has officially announced its exciting participation in several important investor conferences slated for September 2026. This announcement is significant as it showcases Vanda's commitment to transparency and investor engagement in a period where effective communication with stakeholders is crucial for biopharmaceutical companies.

Upcoming Events

The company will present at a series of events, starting with the Wells Fargo 21st Annual Healthcare Conference in Boston, scheduled for Tuesday, September 8, 2026. This will be an excellent platform for Vanda to share its latest achievements, pipeline developments, and strategic vision with a broad audience of healthcare investors and industry professionals.

Following that, Vanda will attend the 2026 Cantor Global Healthcare Conference in New York City on Friday, September 11, 2026. Here, the company will deliver a corporate presentation at 8 a.m. Eastern Time, which can be accessed live via Vanda's corporate website. This opportunity underscores Vanda's proactive approach to keeping investors informed about its trajectory and advancements in therapy development.

On Tuesday, September 15, 2026, Vanda will participate in the H.C. Wainwright 28th Annual Global Investment Conference, where its presentation is also set for 10 a.m. Eastern Time.

Vanda will wrap up this series of conferences at the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on Wednesday, September 16, 2026. These engagements are a vital means for Vanda to reinforce its position in the biopharmaceutical space and to engage with both current and potential investors directly.

Accessing the Presentations

Investors interested in attending Vanda's presentations can easily access the live stream on the company's corporate website (www.vandapharma.com). It is advisable for attendees to log in at least 15 minutes prior to the scheduled start to ensure a seamless experience. Vanda also plans to provide an archived version of these presentations on its website for approximately 30 days following the event, ensuring that those who cannot attend live have the opportunity to catch up on the valuable insights shared.

About Vanda Pharmaceuticals

Vanda Pharmaceuticals is a globally recognized biopharmaceutical organization dedicated to the innovation and commercialization of therapies aimed at addressing significant unmet medical needs. The company’s focus on developing transformative therapies underlines its commitment to enhancing the quality of life for patients facing challenging health conditions. Those interested in obtaining further information about Vanda and its initiatives or products can visit www.vandapharma.com or follow the company on social media at @vandapharma.

In summary, Vanda Pharmaceuticals is poised to maximize its visibility and investor outreach through these crucial investor conferences in September 2026. This proactive approach not only highlights the company's strategic initiatives but also reinforces its commitment to improving patient outcomes in the biopharmaceutical landscape.